Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder

Opioid-use Disorder Clinical Trial

— HOPE MOUD  

Official title:

Adapting the HOPE Online Support Intervention to Increase MAT Uptake Among OUD Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04712981
• Other study ID #: 4R33AT010606 [2020-5625]
• Secondary ID: 4R33AT010606
• Status: Recruiting
• Phase: Phase 2/Phase 3
• Start date: April 29, 2021
• Est. completion date: October 2025

Study information

• Verified date: January 2023
• Source: University of California, Irvine
• Contact: Dominic Ugarte
• Phone: 714-456-8639
• Email: dugarte[@]hs.uci.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In a randomized controlled trial, with 3, 6-month and 1-year follow-up, this application aims to explore whether and how the HOPE intervention can be adapted to increase MOUD uptake among OUD patients, assess the effectiveness of using HOPE to increase MOUD requests, and analyze online community data to improve future intervention implementation and sustainability.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 640
• Est. completion date: October 2025
• Est. primary completion date: July 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. = 18 years of age;

2. Resident of CA, NV, AZ, OR, WA;

3. English speakers only;

4. Has moderate to severe OUD;

5. Is not currently prescribed MOUD;

6. Reports using social media at least 2x per week;

7. Has, or is willing to create a Facebook/social media account and accept a friend request and group invite from our study social media page Exclusion Criteria: -

Related Conditions & MeSH terms

• Opioid-Related Disorders
• Opioid-use Disorder

Intervention

Other:
• Behavioral Intervention
Peer leaders/role models will be trained in HOPE intervention fundamentals and assigned to online community groups with participants.

Locations

Country	Name	City	State
United States	University of California, Irvine	Irvine	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of requests to receive a resource on medications that can be used to treat opioid use disorder	Participants will be invited to request an informational resource on medications for opioid use disorder as well as to ask for assistance scheduling an appointment with a provider on this topic. We will count the number of participants making this request	request during the course of the 12-week community